Sepia Investments and Anchor Partners sold shares worth about Rs 777 crore in Corona Remedies through block deals. HDFC Mutual Fund emerged...

Germany requires international students and job seekers to open a blocked account, known as a Sperrkonto, to prove financial self-sufficien...

Top global investors like SoftBank and KKR have cashed out nearly Rs 18,000 cr from new-age Indian companies post-listing. This marks a shi...

A Bengaluru resident approached the Karnataka High Court after his bank froze his entire account despite police communications seeking a fr...

Fresh funding has propelled Sarvam AI into the unicorn club. This and more in today’s ETtech Top 5.

Prime Minister Keir Starmer intends to ban social media platforms for children under sixteen. This move aims to protect young people's chil...

Asia-focused hedge funds delivered outsized returns in 2026 by riding the artificial intelligence boom across semiconductors and related te...

Lenskart has drawn fresh interest from major institutional investors. This and more in today's ETtech Top 5.

A draft deal between Iran and the United States has been published. This agreement could lead to the release of 24 billion dollars in froze...

PPF maturity presents a choice: withdraw or extend for continued tax-free compounding. While government backing and tax benefits remain att...

Lenskart Solutions saw significant stake activity as marquee investors bought Rs 1,960 crore in a block deal, with Platinum Jasmine A 2018 ...

ADIA-backed Platinum Jasmine A 2018 Trust sold a 2.3% stake in Lenskart through a Rs 1,960 crore block deal. The transaction attracted stro...

Eyewear retailer Lenskart Solutions experienced a significant block deal valued at Rs 1,862 crore. Abu Dhabi Investment Authority, through ...

Abu Dhabi Investment Authority is set to divest a 2.3% stake in Lenskart for approximately Rs 1,944 crore via a block deal. This follows So...

Indian markets experienced a volatile session, closing higher amidst mixed signals. Bulls are defending the 23,000 level in Nifty, but unce...

Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per sha...

A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...